Frazier Life Sciences Management, L.P.
PALO ALTO, CA · CIK 1892134 · 13F filing filed 2022-05-16
SEC-registered investment adviser since 2021 · limited partnership
- Assets managed$7.0bn
- Staff64 · 47 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds8 (1 hedge) · $7.0bn gross assets
- Websitefrazierls.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityFrazier Life Sciences Management, L.P. (US)
- Kindhedge funds, private equity, venture
- Others nearbyPalo Alto, CA, San Diego, CA
As an employer
- Offices in1 country
- Private fundsventure capital 4, hedge 1, private equity 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Palo Alto, CA (main office)United States | about 44 |
| San Diego, CAUnited States | 3 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.2bn
reported value
42positions
60.2%in top 10
—no comparable previous quarter
Holdings, Q1 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $162.4m13.84% | First filing |
| PHATHOM PHARMACEUTICALS INC PHAT | $79.3m6.76% | First filing |
| MIRUM PHARMACEUTICALS INC MIRM | $78.5m6.69% | First filing |
| SIERRA ONCOLOGY INC COM NEW | $75.1m6.40% | First filing |
| KRYSTAL BIOTECH INC KRYS | $57.6m4.91% | First filing |
| IMAGO BIOSCIENCES INC COM | $57.3m4.88% | First filing |
| VAXCYTE INC PCVX | $55.8m4.75% | First filing |
| SYNDAX PHARMACEUTICALS INC SNDX | $55.5m4.73% | First filing |
| CHINOOK THERAPEUTICS INC ADRO | $44.4m3.78% | First filing |
| IVERIC BIO INC OPHT | $40.8m3.47% | First filing |
| ALPINE IMMUNE SCIENCES INC NVLS | $37.5m3.20% | First filing |
| VIRIDIAN THERAPEUTICS INC VRDN | $32.2m2.74% | First filing |
| CRINETICS PHARMACEUTICALS IN CRNX | $31.1m2.65% | First filing |
| BICYCLE THERAPEUTICS PLC BCYC | $26.5m2.26% | First filing |
| TARSUS PHARMACEUTICALS INC TARS | $23.8m2.03% | First filing |
| KALVISTA PHARMACEUTICALS INC KALV | $23.2m1.97% | First filing |
| ANAPTYSBIO INC ANAB | $22.3m1.90% | First filing |
| GRITSTONE BIO INC GRTS | $21.6m1.84% | First filing |
| COGENT BIOSCIENCES INC COGT | $19.9m1.69% | First filing |
| ARVINAS INC ARVN | $18.2m1.55% | First filing |
| TRICIDA INC TCDA | $17.1m1.46% | First filing |
| SILENCE THERAPEUTICS PLC SLN | $16.7m1.43% | First filing |
| MERUS N V MRUS | $16.6m1.42% | First filing |
| AUTOLUS THERAPEUTICS PLC AUTL | $15.6m1.33% | First filing |
| PASSAGE BIO INC COM | $15.5m1.32% | First filing |
| PARDES BIOSCIENCES INC COM | $15.0m1.28% | First filing |
| FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 | $15.0m1.28% | First filing |
| INTELLIA THERAPEUTICS INC NTLA | $14.8m1.26% | First filing |
| SUTRO BIOPHARMA INC COM | $14.6m1.24% | First filing |
| TYRA BIOSCIENCES INC TYRA | $14.2m1.21% | First filing |
| REPLIMUNE GROUP INC REPL | $12.2m1.04% | First filing |
| GRACELL BIOTECHNOLOGIES INC SPONSORED ADS | $8.0m0.68% | First filing |
| ACLARIS THERAPEUTICS INC ACRS | $7.0m0.60% | First filing |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $6.5m0.55% | First filing |
| MOLECULAR TEMPLATES INC COM | $4.7m0.40% | First filing |
| ESSA PHARMA INC EPI | $4.3m0.36% | First filing |
| APTINYX INC COM | $4.3m0.36% | First filing |
| IMMUNOVANT INC IMVT | $3.2m0.28% | First filing |
| SCHOLAR ROCK HLDG CORP SRRK | $2.0m0.17% | First filing |
| CEREVEL THERAPEUTICS HLDNG I CERE | $2.0m0.17% | First filing |
| EPIZYME INC EPZM | $850.0k0.07% | First filing |
| NABRIVA THERAPEUTICS PLC SHS | $179.0k0.02% | First filing |